Home › Agent Hub › Agent Tools › Part D coverage by drug › Humulin R

Agent Tools

Humulin R Part D coverage 2027

Humulin R is a brand of insulin, regular, human. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.

Coverage at a glance

In 2027, 5,245 of 5,492 Medicare Part D and Medicare Advantage drug plans (95.5%) list Humulin R on their formulary, across 278 of 286 formularies. The most common placement is tier 5 (2,572 plans, 49% of those covering it). 25 of the covering plans require prior authorization (0.5%), 0 step therapy and 558 a quantity limit.

What a 30-day fill costs

547 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $40, 231 of them $0; 4,698 charge coinsurance instead — median 25% of the drug's cost. Covered insulin is capped at $35 for a month's supply.

What changed since 2026

2026: 5,215 of 5,496 plans covered it (94.9%); 2027: 5,245 of 5,492 (95.5%).

Of 4,367 plans offered in both years, 1 added it to the formulary and 0 dropped it.

Among plans covering it both years, 249 moved it to a higher tier and 278 to a lower one; 0 added prior authorization and 14 removed it.

Tier placement

By plan type

By carrier

By state

Medicare usage

Medicare Part D paid for 555,716 30-day fills of Humulin R in 2024 for about 86,983 enrollees, at an average total cost of $437.22 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).

Related

• Novolin R

Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.